Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Free Cash Flow Growth (3y) (2025 - 2026)

Analysis

Bioregenx (BRGX) Free Cash Flow Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 41.96%
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 24.84%
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 35.29%
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 25.48%
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 35.42%
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 250.09%
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 12.01%
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 25.74%
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 11.09%
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 27.63%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 27.63%
Dec 31, 2025 158.41%
Sep 30, 2025 -131.42%
Jun 30, 2025 27.99%
Mar 31, 2025 56.07%
API Access

Bioregenx Free Cash Flow Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow-growth-3y&ticker=BRGX&period=max&api_key=YOUR_API_KEY